New GMP Rules for Combination Products: Are you ready on 22 July 2013?

Event Information
Product Format
Prerecorded Event
90 Minutes
Product Description

Understand the Core concepts of GMP for Combination Products with Our Expert

In January 2013 FDA released the long-sought after rules for cGMPs for combination products.
These rules that had been in the works for about 8 years clarified several confusions about FDA expectations regarding GMP requirements for products that may be subject to multiple GMP requirements from drugs, biologics and medical devices depending on their components. In the final rule, FDA clarified the acceptable definitions, described the applicable regulations, and provided advice on which GMP requirements to follow for a given product. The final rule also defined FDA’s expectation for co-packaged or single-entity combination products.

Developers and manufacturers of combination products are required to follow these rules starting 22 July 2013. Are you ready?

Certainly, with this healthcare session! Our expert Dr. Mukesh Kumar will discuss the final rule for GMP requirements for combination products highlighting the key elements of the rule and practical tips for compliance. FDA’s rationale for various requirements and expectations of manufacturing sites involved in combination products will be discussed using examples and case studies.

Here are a few highlights of the session:

  • FDA’s rationale for these new GMP requirements
  • Essential requirements as of July 23, 2013
  • GMP requirements for the individual components of and the combination product as a whole
  • Special considerations for vendors and suppliers of components
  • Major industry concerns about implementing the new Rule and potential solutions

Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.

Who should attend?

  • Compliance/Regulatory affairs professionals
  • Managers of GMP facilities
  • Supply chain managers
  • QA directors, managers and personnel
  • GMP site personnel
  • Senior managers of companies using CMOs
  • People investing in FDA-regulated products

Order Below or Call 1-866-458-2965 Today

You can also order through:




About Our Speaker

Dr. Mukesh Kumar - Pharma Regulation Expert

Dr. Mukesh Kumar is a Washington DC-based consultant in regulatory affairs and quality assurance for manufacturers and developers of FDA-regulated products. He leads the Regulatory Affairs and Quality Assurance departments at Amarex, a full service pharmaceutical product development company based in Germantown, MD ( His key expertise is in regulatory affairs, clinical trials, and multi-national project management for medicinal and diagnostic products. He has been involved in about 100...   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus